VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT
VistaGen Therapeutics Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 244K | -15K | 234K | 183K | 84K | 197.3K | 411.4K | 278K | 177K | 175.6K | 179.6K | -892.5K | 310.1K | 38.9K | 357.9K | 358K | 354.1K | 441.9K | 313.6K | 334K | n/a |
Cost of Revenue | 169K | 161K | 161K | 157K | 151K | 146.5K | 143.2K | 140.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 75K | -15K | 234K | 183K | 84K | 197.3K | 411.4K | 278K | 177K | 175.6K | 179.6K | -892.5K | 310.1K | 38.9K | 357.9K | 358K | 354.1K | 441.9K | 313.6K | 334K | n/a |
Operating Income | -15.8M | -14.49M | -15.12M | -14.23M | -12.13M | -11.36M | -7.88M | -6.78M | -7M | -12.24M | -9.77M | -17.49M | -19.77M | -16.69M | -10.54M | -12.8M | -7.75M | -6.22M | -5.3M | -3.29M | -3.12M |
Interest Income | 711K | 855K | 1.03M | 1.27M | 1.4M | 1.53M | 1.53M | 192K | 103.2K | 15K | 11.3K | 15.1K | 6K | 5K | 5K | 5K | 5K | 9K | 4K | 2K | n/a |
Pretax Income | -15.1M | -13.63M | -14.09M | -12.95M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M | -12.23M | -9.76M | -17.48M | -19.77M | -16.69M | -10.54M | -12.79M | -7.74M | -6.21M | -5.3M | -3.3M | -3.12M |
Net Income | -15.1M | -13.63M | -14.09M | -12.96M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M | -12.23M | -9.76M | -17.48M | -19.78M | -16.69M | -10.54M | -12.79M | -7.74M | -6.21M | -5.3M | -3.3M | -3.13M |
Selling & General & Admin | 4.37M | 4.27M | 4.05M | 4.2M | 4.57M | 4.12M | 3.76M | 3.21M | 2.98M | 3.15M | 3.09M | 3.7M | 4.79M | 4.96M | 3.12M | 3.22M | 2.41M | 1.77M | 2.12M | 1.27M | 1.39M |
Research & Development | 11.68M | 10.21M | 11.3M | 10.21M | 7.65M | 7.44M | 4.54M | 3.85M | 4.2M | 9.34M | 6.85M | 12.89M | 15.29M | 11.77M | 7.78M | 9.94M | 5.46M | 4.89M | 3.5M | 2.36M | 1.73M |
Other Expenses | -169K | n/a | n/a | n/a | n/a | -300 | -200 | n/a | n/a | -77.6K | 100.00 | 300.00 | -200 | 200.00 | 100.00 | 200.00 | 232.1K | n/a | -200 | -500 | -400 |
Operating Expenses | 15.88M | 14.48M | 15.35M | 14.41M | 12.21M | 11.56M | 8.3M | 7.06M | 7.17M | 12.41M | 9.95M | 16.6M | 20.08M | 16.73M | 10.9M | 13.16M | 8.1M | 6.66M | 5.61M | 3.63M | 3.12M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 3K | 6K | 9K | 4K | n/a | n/a | n/a | n/a | 1K | 3K | 6K | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 84K | n/a | n/a | 1.3M | 1.37M | 846K | 475K | 102K | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.05M | 14.48M | 15.35M | 14.41M | 12.21M | 11.56M | 8.3M | 7.06M | 7.17M | 12.41M | 9.95M | 16.6M | 20.08M | 16.73M | 10.9M | 13.16M | 8.1M | 6.66M | 5.61M | 3.63M | 3.12M |
Income Tax Expense | n/a | n/a | n/a | 7K | n/a | 1.5K | n/a | n/a | 3K | 400.00 | n/a | n/a | 5.5K | n/a | n/a | n/a | 3.4K | n/a | n/a | 200.00 | 2.4K |
Shares Outstanding (Basic) | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M | 7.16M | 6.89M | 6.89M | 6.89M | 6.88M | 6.74M | 6.44M | 6.33M | 4.83M | 2.7M | 2.24M | 1.71M |
Shares Outstanding (Diluted) | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M | 7.16M | 6.89M | 6.89M | 6.89M | 6.88M | 6.74M | 6.44M | 6.33M | 4.83M | 2.7M | 2.24M | 1.71M |
EPS (Basic) | -0.47 | -0.44 | -0.46 | -0.42 | -0.35 | -0.35 | -0.43 | -0.66 | -0.94 | -1.71 | -1.42 | -2.54 | -2.87 | -2.43 | -1.56 | -1.99 | -1.22 | -1.29 | -1.96 | -1.47 | -1.83 |
EPS (Diluted) | -0.47 | -0.44 | -0.46 | -0.42 | -0.35 | -0.35 | -0.43 | -0.66 | -0.94 | -1.71 | -1.42 | -2.54 | -2.87 | -2.43 | -1.56 | -1.99 | -1.22 | -1.29 | -1.96 | -1.47 | -1.83 |
EBITDA | -14.93M | -14.33M | -14.96M | -14.07M | -11.98M | -11.21M | -7.74M | -6.64M | -6.86M | -12.09M | -9.63M | -17.36M | -19.64M | -16.55M | -10.22M | -12.66M | -7.61M | -6.17M | -5.18M | -3.09M | -3.1M |
EBIT | -15.1M | -14.49M | -15.12M | -14.23M | -12.13M | -11.36M | -7.88M | -6.78M | -7M | -12.22M | -9.77M | -17.49M | -19.77M | -16.69M | -10.54M | -12.79M | -7.74M | -6.21M | -5.3M | -3.29M | -3.12M |
Depreciation & Amortization | 169K | 166K | 161K | 157K | 151K | 146.5K | 143.5K | 139K | 139K | 137.1K | 132.2K | 132.6K | 129.3K | 133.4K | 316K | 132.9K | 128.8K | 40.3K | 117.2K | 202.2K | 25.4K |